BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.
暂无分享,去创建一个
K Offit | A Oliphant | S. Loader | M. Skolnick | A. Oliphant | P. Rowley | R. Burgemeister | L. Cannon-Albright | D. Teng | K. Offit | B. Ward | H. Nevanlinna | S. Tavtigian | D. Pruss | Alun Thomas | N. Adey | T. Rubano | J. Garber | C. Isaacs | P. Radice | C. McBride | B. Peshkin | S. Manley | M. Pierotti | R. Lundstrom | M. Luce | D. Shattuck-Eidens | M. Lippman | M. Daly | R. Pilarski | H. Hampel | A. Thomas | R. Greenstein | M. Osborne | M. Caligo | L. Steele | E. Giulotto | J. Holmén | M. McClure | F. Fujimura | S Manley | M. Hulick | B. Lingenfelter | K. Gumpper | T. Gilewski | A. Ravaioli | L Steele | W. Zoli | R Lundstrom | C McBride | T Rubano | D H Teng | S V Tavtigian | J. Gupte | D. Pruss | M. Staebell | M. Kelly | M. Luce | K. T. Brown | D Shattuck-Eidens | M McClure | J Gupte | D Pruss | N Adey | M Staebell | K Gumpper | M Hulick | M Kelly | J Holmen | B Lingenfelter | F Fujimura | M Luce | B Ward | L Cannon-Albright | A Thomas | S. Pyrhonen | J. Holmen | M. Dosik | I. Tepler | A. Schluger | P. L. Weinstein | Larry Norton | Rodney J. Scott | Barbara L. Weber | M. Mcclure | T. S. Frank | Celeste McBride | Charlene J. Schulz | Kathryn Gumpper | Mark Staebell | Mark Kelly | Jennifer Scalia | Richard Michaelson
[1] Anne M. Bowcock,et al. Identification of a RING protein that can interact in vivo with the BRCA1 gene product , 1996, Nature Genetics.
[2] H. Anton-Culver,et al. Detection of BRCA1 mutations by the protein truncation test. , 1995, Human molecular genetics.
[3] D. Easton,et al. Risks of cancer in BRCA1-mutation carriers , 1994, The Lancet.
[4] Steven E. Bayer,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.
[5] Alfred A. Boyd,et al. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2 , 1996, Nature Genetics.
[6] M. Skolnick,et al. Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations. , 1996, Human molecular genetics.
[7] D. B. Berman,et al. Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds. , 1996, American journal of human genetics.
[8] P. Hartge,et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. , 1997, The New England journal of medicine.
[9] E. Solomon,et al. The 5' end of the BRCA1 gene lies within a duplicated region of human chromosome 17q21. , 1996, Oncogene.
[10] J. Eyfjörd,et al. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes , 1996, Nature Genetics.
[11] L. Tsui,et al. A suggested nomenclature for designating mutations , 1993, Human mutation.
[12] H. Anton-Culver,et al. BRCA1 R841W: A strong candidate for a common mutation with moderate phenotype , 1996 .
[13] C. Larsson,et al. Mutation analysis of the BRCA2 gene in 49 site–specific breast cancer families , 1996, Nature Genetics.
[14] Eugene V. Koonin,et al. …Functional motifs… , 1996, Nature Genetics.
[15] J. Klijn,et al. Rapid detection of BRCA1 mutations by the protein truncation test , 1995, Nature Genetics.
[16] Yumay Chen,et al. The Nuclear Localization Sequences of the BRCA1 Protein Interact with the Importin-α Subunit of the Nuclear Transport Signal Receptor* , 1996, The Journal of Biological Chemistry.
[17] W. Thompson,et al. The genetic attributable risk of breast and ovarian cancer , 1996, Cancer.
[18] F. Couch,et al. Mutations and Polymorphisms in the familial early‐onset breast cancer (BRCA1) gene , 1996, Human mutation.
[19] F. Couch,et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. , 1997, The New England journal of medicine.
[20] Kenneth Offit,et al. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1% , 1996, Nature Genetics.
[21] P. Tonin,et al. A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. , 1996, American Journal of Human Genetics.
[22] J. D. Thompson,et al. BRCA1 mutations in a population-based sample of young women with breast cancer. , 1996, The New England journal of medicine.
[23] D. B. Berman,et al. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families , 1996, Nature Medicine.
[24] M. Skolnick,et al. Statement of the American Society of Clinical Oncology : Genetic testing for cancer susceptibility. Commentaries , 1996 .
[25] G. Lenoir,et al. A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17. , 1997, Cancer research.